Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Protral Opas sustained-release tamsulosin tablet vs Protral tamsulosin capsule on retrograde ejaculation
IRCT20200112046093N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tamsulosin in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Aja University of Medical Sciences. Primary endpoint: Incidence of retrograde ejaculation. Started Mar 2020; status: completed.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20200112046093N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200112046093N1.